These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12412393)

  • 1. The therapeutic role of dendritic cells in cancer immunotherapy.
    Lemoli RM; Curti A; Fogli M; Ferri E; Baccarani M
    Haematologica; 2002 Aug; 87(8 Suppl):62-6. PubMed ID: 12412393
    [No Abstract]   [Full Text] [Related]  

  • 2. Dendritic cell immunotherapy for the treatment of neoplastic disease.
    Decker WK; Xing D; Shpall EJ
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):113-25. PubMed ID: 16443510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells as vectors for immunotherapy of cancer.
    Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK
    Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential applications for plasmacytoid dendritic cells in cancer immunotherapy.
    Tel J; de Vries IJ
    Immunotherapy; 2012 Oct; 4(10):979-82. PubMed ID: 23148748
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor-dendritic cell fusion technology and immunotherapy strategies.
    Shu S; Cohen P
    J Immunother; 2001; 24(2):99-100. PubMed ID: 11265778
    [No Abstract]   [Full Text] [Related]  

  • 6. Dendritic cell-based cancer therapy.
    Conrad C; Nestle FO
    Curr Opin Mol Ther; 2003 Aug; 5(4):405-12. PubMed ID: 14513684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy with dendritic cells for cancer.
    Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A
    Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunotherapy with dendritic cells in cancer: current status.
    Nencioni A; Brossart P
    Stem Cells; 2004; 22(4):501-13. PubMed ID: 15277696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells as therapeutic vaccines against cancer.
    Banchereau J; Palucka AK
    Nat Rev Immunol; 2005 Apr; 5(4):296-306. PubMed ID: 15803149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte-derived dendritic cells: a promising armament for immunotherapy in human malignancies.
    Yi Q; Kwak LW
    Clin Cancer Res; 2005 Feb; 11(3):966-7. PubMed ID: 15709160
    [No Abstract]   [Full Text] [Related]  

  • 11. Dendritic cell immunotherapy: mapping the way.
    Figdor CG; de Vries IJ; Lesterhuis WJ; Melief CJ
    Nat Med; 2004 May; 10(5):475-80. PubMed ID: 15122249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells in cancer immunotherapy - a short review.
    Wojas K; Tabarkiewicz J; Roliński J
    Folia Morphol (Warsz); 2003 Nov; 62(4):317-8. PubMed ID: 14655109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer therapy-induced immune modulation.
    Karl JC; Mackall CL
    Cancer Chemother Biol Response Modif; 2005; 22():325-41. PubMed ID: 16110619
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal control in a model of dendritic cell transfection cancer immunotherapy.
    Castiglione F; Piccoli B
    Bull Math Biol; 2006 Feb; 68(2):255-74. PubMed ID: 16794930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer immunotherapy using dendritic cells: current status and perspective].
    Okano S; Yonemitsu Y; Sueishi K
    Fukuoka Igaku Zasshi; 2007 Jul; 98(7):277-86. PubMed ID: 17710892
    [No Abstract]   [Full Text] [Related]  

  • 16. The hybrid cell vaccination approach to cancer immunotherapy.
    Trefzer U; Herberth G; Sterry W; Walden P
    Ernst Schering Res Found Workshop; 2000; (30):154-66. PubMed ID: 10943322
    [No Abstract]   [Full Text] [Related]  

  • 17. DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy.
    Schultze JL; Grabbe S; von Bergwelt-Baildon MS
    Trends Immunol; 2004 Dec; 25(12):659-64. PubMed ID: 15530836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
    Dullaers M; Thielemans K
    J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poxviruses as vectors for cancer immunotherapy.
    Kwak H; Hörig H; Kaufman HL
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):161-8. PubMed ID: 12669450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Witch hunt against tumor cells enhanced by dendritic cells.
    Locher C; Rusakiewicz S; Tesnière A; Ghiringhelli F; Apetoh L; Kroemer G; Zitvogel L
    Ann N Y Acad Sci; 2009 Sep; 1174():51-60. PubMed ID: 19769736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.